BMA
Overvalued by 98.7% based on the discounted cash flow analysis.
Market cap | $5.86 Billion |
---|---|
Enterprise Value | $-2,159,318,921,774.00 |
Dividend Yield | $5.30404 (7.28513406896552%) |
Earnings per Share | $5090.6 |
Beta | 0.91 |
Outstanding Shares | 63,900,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 21.36 |
---|---|
PEG | -28.83 |
Price to Sales | 0.0 |
Price to Book Ratio | 0.0 |
Enterprise Value to Revenue | -0.44 |
Enterprise Value to EBIT | -7.73 |
Enterprise Value to Net Income | -19 |
Total Debt to Enterprise | -0.28 |
Debt to Equity | 0.15 |
No data
No data